262 results Stibbe advises client in the pharmaceutical sector Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products. Stibbe advises Friesland Bank Advising Friesland Bank on its separation from Stichting Friesland Bank and its merger into Rabobank Nederland. Stibbe advises Forbion Capital Partners Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding. Stibbe advises Dutch pension funds Advising several Dutch pension funds in connection with enforcement action taken by the Dutch Central Bank in view of actual or threatened failure to satisfy capital adequacy requirements. Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products. Stibbe advises on the contemplated IPO of Agendia Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency. Stibbe advises on the IPO of Tornier Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix. E-book: 'Sustainable Finance in Europe' Stibbe lawyers Marieke Driessen, Loes van Dijk and Ingrid van der Klooster contributed to the book 'Sustainable Finance in Europe' which was recently published. Consultatievoorstel voor Wijzigingswet toezicht financiële markten 2024 Ingrid van der Klooster bespreekt de hoofdlijnen van de voorgestelde wijzigingen in het consultatievoorstel dat op 29 april 2022 gepubliceerd is. European Commission Updates High-Risk Third Countries List The European Commission adopted a Delegated Regulation (EU/2025/1184) amending its list of high-risk third countries under the Anti-Money Laundering and Anti-Terrorism Financing Directive. Op naar hoe: de volgende stap in het AFM-toezicht op duurzaamheidsclaims De Autoriteit Financiële Markten (AFM) maant financiële ondernemingen tot uitgebreidere, concretere en duidelijkere communicatie over duurzaamheid. ECB’s review of management bodies of EU banks Early 2023, the European Central Bank (ECB) conducted a review of management bodies in a sample of 20 banks across the European Union. The Draghi Report: a reality check for ESG regulation in the EU On 17 September 2024, former president of the European Central Bank Mario Draghi published his report to the European Commission with observations on Europe’s sustainable competitiveness and recommendations for Europe’s future. Shareholding filings by listed companies and their shareholders Navigating the various AFM shareholding notification obligations in the Netherlands for listed companies and their shareholders can be complex. Emilie Renardel de Lavalette published an article breaking down the required filings. The latest Legal Updates straight to your mailbox We publish high-quality legal knowledge and insights on our website on a daily basis. If you would like to be promptly informed about the latest developments within your areas of interest, we invite you to sign up for our Legal Updates. Pagination Previous page Page 11 Current page 12 Page 13 Page 14 Next page
Stibbe advises client in the pharmaceutical sector Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products.
Stibbe advises Friesland Bank Advising Friesland Bank on its separation from Stichting Friesland Bank and its merger into Rabobank Nederland.
Stibbe advises Forbion Capital Partners Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding.
Stibbe advises Dutch pension funds Advising several Dutch pension funds in connection with enforcement action taken by the Dutch Central Bank in view of actual or threatened failure to satisfy capital adequacy requirements.
Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.
Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.
Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.
E-book: 'Sustainable Finance in Europe' Stibbe lawyers Marieke Driessen, Loes van Dijk and Ingrid van der Klooster contributed to the book 'Sustainable Finance in Europe' which was recently published.
Consultatievoorstel voor Wijzigingswet toezicht financiële markten 2024 Ingrid van der Klooster bespreekt de hoofdlijnen van de voorgestelde wijzigingen in het consultatievoorstel dat op 29 april 2022 gepubliceerd is.
European Commission Updates High-Risk Third Countries List The European Commission adopted a Delegated Regulation (EU/2025/1184) amending its list of high-risk third countries under the Anti-Money Laundering and Anti-Terrorism Financing Directive.
Op naar hoe: de volgende stap in het AFM-toezicht op duurzaamheidsclaims De Autoriteit Financiële Markten (AFM) maant financiële ondernemingen tot uitgebreidere, concretere en duidelijkere communicatie over duurzaamheid.
ECB’s review of management bodies of EU banks Early 2023, the European Central Bank (ECB) conducted a review of management bodies in a sample of 20 banks across the European Union.
The Draghi Report: a reality check for ESG regulation in the EU On 17 September 2024, former president of the European Central Bank Mario Draghi published his report to the European Commission with observations on Europe’s sustainable competitiveness and recommendations for Europe’s future.
Shareholding filings by listed companies and their shareholders Navigating the various AFM shareholding notification obligations in the Netherlands for listed companies and their shareholders can be complex. Emilie Renardel de Lavalette published an article breaking down the required filings.
The latest Legal Updates straight to your mailbox We publish high-quality legal knowledge and insights on our website on a daily basis. If you would like to be promptly informed about the latest developments within your areas of interest, we invite you to sign up for our Legal Updates.